The Manufacturers Life Insurance Company Decreases Stock Holdings in Palomar Holdings, Inc. $PLMR

The Manufacturers Life Insurance Company reduced its position in shares of Palomar Holdings, Inc. (NASDAQ:PLMR) by 12.8% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 64,132 shares of the company’s stock after selling 9,431 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.24% of Palomar worth $7,664,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. purchased a new position in shares of Palomar in the fourth quarter valued at about $32,000. Kestra Advisory Services LLC purchased a new stake in Palomar in the 4th quarter worth approximately $33,000. Rockefeller Capital Management L.P. lifted its holdings in Palomar by 81.5% in the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after buying an additional 132 shares during the period. Parallel Advisors LLC grew its position in shares of Palomar by 638.3% in the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock worth $53,000 after buying an additional 383 shares during the last quarter. Finally, Frazier Financial Advisors LLC purchased a new stake in Palomar in the fourth quarter worth $54,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Palomar Stock Down 0.3%

PLMR stock opened at $136.11 on Wednesday. The business has a 50 day moving average of $125.19 and a 200 day moving average of $123.58. The firm has a market cap of $3.61 billion, a PE ratio of 18.96 and a beta of 0.40. Palomar Holdings, Inc. has a twelve month low of $100.81 and a twelve month high of $147.62. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31.

Palomar (NASDAQ:PLMR) last released its earnings results on Tuesday, August 4th. The company reported $2.36 EPS for the quarter, topping the consensus estimate of $2.19 by $0.17. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The business had revenue of $314.42 million for the quarter, compared to the consensus estimate of $621.52 million. During the same period in the previous year, the company posted $1.76 earnings per share. On average, research analysts forecast that Palomar Holdings, Inc. will post 8.9 EPS for the current fiscal year.

Palomar Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 2nd. Stockholders of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. The ex-dividend date is Wednesday, August 19th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.3%.

Insiders Place Their Bets

In other Palomar news, President Jon Christianson sold 3,000 shares of Palomar stock in a transaction on Monday, July 20th. The stock was sold at an average price of $139.50, for a total value of $418,500.00. Following the completion of the sale, the president owned 66,478 shares of the company’s stock, valued at approximately $9,273,681. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mac Armstrong sold 3,500 shares of Palomar stock in a transaction dated Tuesday, July 21st. The stock was sold at an average price of $137.26, for a total value of $480,410.00. Following the completion of the sale, the chief executive officer owned 325,888 shares of the company’s stock, valued at $44,731,386.88. The trade was a 1.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 22,050 shares of company stock valued at $2,875,050. 3.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on PLMR shares. Zacks Research downgraded shares of Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Keefe, Bruyette & Woods increased their price target on shares of Palomar from $162.00 to $166.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 8th. Piper Sandler raised their price objective on shares of Palomar from $132.00 to $165.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Weiss Ratings upgraded Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th. Finally, JPMorgan Chase & Co. lifted their price target on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $162.50.

Palomar News Roundup

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar reported second-quarter EPS of $2.36, exceeding analysts’ $2.19 consensus estimate by $0.17 and rising from $1.76 in the prior-year quarter. The company also posted a 22.62% return on equity and a 20.11% net margin. Palomar Holdings, Inc. Reports Second Quarter 2026 Results
• Neutral Sentiment: COO Rodolphe Herve sold 1,207 shares worth approximately $163,367. The filing said the transaction was intended to cover tax-withholding obligations tied to vested equity awards, making it less indicative of a bearish view on the company. Palomar insider transaction
• Negative Sentiment: Revenue was reported at $314.42 million, well below the approximately $621.5 million analyst expectation cited in the earnings coverage. Even with the EPS beat, the reported top-line miss could raise concerns about growth and operating performance. Palomar Q2 Earnings Snapshot
• Negative Sentiment: Zacks Research lowered its fiscal 2028 EPS estimate to $10.45 from $10.62 and maintained a “Hold” rating. The revision signals somewhat weaker longer-term earnings expectations, although the current-year consensus remains $8.90 per share. Palomar analyst estimate revision

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.